• February 6, 2019
• 0

Britain's largest drugmaker GlaxoSmithKline has announced its 2018 financial results, showing that the company is making progress in rebuilding its pharmaceutical pipeline despite competition from generics. However the company has also...

• January 12, 2019
• 0

GlaxoSmithKline (GSK) have completed a deal worth approximately $5.1bn in its acquisition of oncology-focused biopharmaceutical company Tesaro. GSK have stated the merger will significantly boost its pharmaceutical portfolio as well...

• January 11, 2019
• 0

A large study led by University College London (UCL) has found that statins and other medications have significant benefit in patients with some form of mental illness. The study, involving...